Study of Chemosensory Enhancement Through Neuromodulation Training (SCENT for Long COVID)
RecruitingNCT05855369Phase: PHASE2, PHASE3Started 2023-10-02
Summary
Persistent smell loss that can include diminished or distorted smell function is a common symptom of long COVID syndrome. There are limited treatment options for long COVID-related smell loss. This st
Eligibility
Sex
ALL
Min Age
18 Years
Max Age
65 Years
Locations
Medical University of South CarolinaCharleston, South Carolina, United States
View full study details on ClinicalTrials.gov
clinicaltrials.gov/study/NCT05855369